Ray Dalio’s Halozyme HALO Stock Holding History

Ray Dalio’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.1M	Sell	511,429 -50,148	-9%	-$3.54M	0.15%	104
2025 Q4	$37.8M	Buy	561,577 +74,496	+15%	+$5.01M	0.14%	118
2025 Q3	$35.7M	Buy	+487,081	New	+$32.4M	0.14%	118
2024 Q4	–	Sell	-11,515	Closed	-$659K	–	748
2024 Q3	$659K	Sell	11,515 -21,706	-65%	-$1.24M	﹤0.01%	661
2024 Q2	$1.74M	Buy	33,221 +26,159	+370%	+$1.15M	0.01%	558
2024 Q1	$287K	Hold	7,062	–	–	﹤0.01%	659
2023 Q4	$261K	Hold	7,062	–	–	﹤0.01%	734
2023 Q3	$270K	Sell	7,062 -54,533	-89%	-$2.23M	﹤0.01%	727
2023 Q2	$2.22M	Buy	+61,595	New	+$2.1M	0.01%	446

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ray Dalio's HALO Position: Q1 2026 in Review

Ray Dalio reduced its Halozyme (HALO) stake by 8.9% in Q1 2026, selling an estimated $3.54M and leaving 511,429 shares worth $33.1M. The position accounts for 0.15% of the portfolio, ranked #104.

Ray Dalio first reported a position in HALO in Q2 2023 and has held it in 9 quarters since. The position peaked at $37.8M in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Ray Dalio held 511,429 shares of Halozyme worth $33.1M as of Q1 2026.
Ray Dalio sold 50,148 Halozyme shares in Q1 2026, an estimated $3.54M.
Halozyme made up 0.15% of Ray Dalio's portfolio in Q1 2026, its #104 holding.
Ray Dalio first reported a position in Halozyme in Q2 2023 and has held it in 9 quarters since.
Ray Dalio's Halozyme position peaked at $37.8M in Q4 2025.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.